Results 41 to 50 of about 38,655 (210)
British Journal of Dermatology, 2021 Dear Editor, Growing evidence suggests that SARS-CoV-2 vaccination is associated with a variety of cutaneous reactions, also including autoimmune-mediated conditions such as autoimmune blistering diseases such as bullous pemphigoid (BP).1,2 We report new-
T. Gambichler +15 more
semanticscholar +1 more source
JEADV Clinical Practice, 2023 Bullous pemphigoid is a rare complication of immune checkpoint inhibitor treatment. We report a case of pembrolizumab‐induced bullous pemphigoid in a patient with malignant melanoma and concomitant cutaneous squamous cell carcinoma that regressed.
Shin Iinuma +2 more
doaj +1 more source
Bullous Pemphygoid and Novel Therapeutic Approaches
Biomedicines, 2022 Bullous pemphigoid is a subepidermal blistering disease associated with autoantibodies (auto-ab) to BP180 and BP230 which affects elderly patients, predominately.
Giovanni Marco D’Agostino +10 more
doaj +1 more source
Journal of the European Academy of Dermatology and Venereology, 2021 While clustering of bullous pemphigoid (BP) with neuropsychiatric diseases is well‐established, the clinical and immunological profile of BP patients with this comorbidity remains to be decisively determined.
S. Ständer +9 more
semanticscholar +1 more source
Correlation between bullous pemphigoid and type 2 inflammation
Pifu-xingbing zhenliaoxue zazhi, 2022 Bullous pemphigoid (BP) is one of the common autoimmune blister diseases that mainly affects the elderly. Most bullous pemphigoid patients have obvious symptom of pruritus, accompanied by elevated levels of serum total IgE, peripheral blood eosinophils ...
Yao ZHOU +6 more
doaj +1 more source
Dermatology Online Journal, 2021 Bullous pemphigoid is an autoimmune skin disease that results in formation of pruritic blisters. Most cases are treated with a combination of systemic and topical corticosteroids as well as other immunomodulatory drugs.
M. Saleh +3 more
semanticscholar +1 more source
New-Onset Bullous Pemphigoid in a COVID-19 Patient
Case Reports in Dermatological Medicine, 2021 This manuscript presents a report of bullous pemphigoid rash associated with COVID-19 for the first time. The objective of this manuscript is to present a unique dermatological case in the setting of a COVID-19-positive infection to further recognize the
N. Olson, David Eckhardt, Angela Delano
semanticscholar +1 more source
S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid: 2019 update
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2020 (1) Department of Dermatology, University of Lübeck, Lübeck, Germany (2) Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany (3) Department of Dermatology, University Hospital Erlangen, Erlangen, Germany (4) Department of ...
Enno Schmidt +17 more
semanticscholar +1 more source
The impact of lesional inflammatory cellular infiltrate on the phenotype of bullous pemphigoid
Journal of the European Academy of Dermatology and Venereology, 2021 The influence of cutaneous cellular infiltration on the phenotype of bullous pemphigoid (BP) remains to be established.
S. Ständer +8 more
semanticscholar +1 more source
Lower Extremity Salvage in the Setting of Bullous Pemphigoid Exacerbation: A Case Report
Plastic and Reconstructive Surgery, Global Open, 2021 Summary:. Bullous pemphigoid is an autoimmune blistering disease where patients suffer from painful bullae, often covering large portions of the skin and requiring management with immune-suppression.
Samara E. Pollock, MD +5 more
doaj +1 more source